Metabolomics in rheumatoid arthritis with versus without disease-modifying antirheumatic drug initiation
Introduction: Rheumatoid arthritis (RA) significantly increases the overall risk of cardiovascular disease (CVD). In addition to conventional risk factors, the inflammatory activity of the disease itself and medications that promote atherosclerosis contribute to an even greater risk. However, there [for full text, please go to the a.m. URL]
Institutions
- Universitätsklinikum Brandenburg an der Havel (DE)
- University of Regensburg (DE)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2024-09-18
- DOI
- https://doi.org/10.3205/24dgrh159
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00